Justin Ward
Director/Board Member at RECCE PHARMACEUTICALS LTD
Net worth: 129 190 $ as of 2024-04-29
Profile
Justin Ward is currently the Executive Director & Manager-Quality Assurance at Recce Pharmaceuticals Ltd.
He previously worked as a Laboratory Manager at Solbec Pharmaceuticals Ltd.
and as a Quality Manager at Phebra Pty Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-12-06 | 301,444 ( 0.15% ) | 129 190 $ | 2024-04-29 |
Justin Ward active positions
| Companies | Position | Start |
|---|---|---|
| RECCE PHARMACEUTICALS LTD | Director/Board Member | 2019-07-08 |
Former positions of Justin Ward
| Companies | Position | End |
|---|---|---|
Phebra Pty Ltd.
 Phebra Pty Ltd. Pharmaceuticals: MajorHealth Technology Phebra Pty Ltd. is an Australian-based specialty pharmaceutical group that develops, manufactures, and markets critical medicines worldwide. The private company is based in Lane Cove, AU, and has subsidiaries in the United Kingdom. The Australian company creates critical medicines that save and improve lives. Phebra was founded in 1993, and the CEO is Andre Vlok. | Corporate Officer/Principal | - |
| Solbec Pharmaceuticals Ltd. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RECCE PHARMACEUTICALS LTD | Health Technology |
| Private companies | 2 |
|---|---|
| Solbec Pharmaceuticals Ltd. | Health Technology |
Phebra Pty Ltd.
Phebra Pty Ltd. Pharmaceuticals: MajorHealth Technology Phebra Pty Ltd. is an Australian-based specialty pharmaceutical group that develops, manufactures, and markets critical medicines worldwide. The private company is based in Lane Cove, AU, and has subsidiaries in the United Kingdom. The Australian company creates critical medicines that save and improve lives. Phebra was founded in 1993, and the CEO is Andre Vlok. | Health Technology |
- Stock Market
- Insiders
- Justin Ward